TY - JOUR
T1 - Correction to
T2 - Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results (Pituitary, (2021), 24, 6, (943-953), 10.1007/s11102-021-01163-2)
AU - Labadzhyan, Artak
AU - Nachtigall, L. B.
AU - Fleseriu, M.
AU - Gordon, M. B.
AU - Molitch, M.
AU - Kennedy, L.
AU - Samson, S. L.
AU - Greenman, Y.
AU - Biermasz, N.
AU - Bolanowski, M.
AU - Haviv, A.
AU - Ludlam, W.
AU - Patou, G.
AU - Strasburger, C. J.
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - The article ‘Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results’, written by Artak Labadzhyan, L B Nachtigall, M Fleseriu, M B Gordon, M Molitch, L Kennedy, S L Samson, Y Greenman, N Biermasz, M Bolanowski, A Haviv, W Ludlam, G Patou and C J Strasburger was originally published electronically on the publisher’s internet portal on 25 June 2021 without open access.
AB - The article ‘Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results’, written by Artak Labadzhyan, L B Nachtigall, M Fleseriu, M B Gordon, M Molitch, L Kennedy, S L Samson, Y Greenman, N Biermasz, M Bolanowski, A Haviv, W Ludlam, G Patou and C J Strasburger was originally published electronically on the publisher’s internet portal on 25 June 2021 without open access.
UR - http://www.scopus.com/inward/record.url?scp=85113168886&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113168886&partnerID=8YFLogxK
U2 - 10.1007/s11102-021-01177-w
DO - 10.1007/s11102-021-01177-w
M3 - Comment/debate
C2 - 34347226
AN - SCOPUS:85113168886
SN - 1386-341X
VL - 24
SP - 954
JO - Pituitary
JF - Pituitary
IS - 6
ER -